Explore the words cloud of the MetaboliQs project. It provides you a very rough idea of what is the project "MetaboliQs" about.
The following table provides information about the project.
Coordinator |
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V.
Organization address contact info |
Coordinator Country | Germany [DE] |
Total cost | 6˙667˙801 € |
EC max contribution | 6˙667˙801 € (100%) |
Programme |
1. H2020-EU.1.2.3. (FET Flagships) |
Code Call | H2020-FETFLAG-2018-03 |
Funding Scheme | RIA |
Starting year | 2018 |
Duration (year-month-day) | from 2018-10-01 to 2021-09-30 |
Take a look of project's partnership.
# | ||||
---|---|---|---|---|
1 | FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V. | DE (MUNCHEN) | coordinator | 1˙500˙172.00 |
2 | NVISION IMAGING TECHNOLOGIES GMBH | DE (ULM) | participant | 1˙430˙937.00 |
3 | KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITAT MUNCHEN | DE (MUENCHEN) | participant | 1˙220˙401.00 |
4 | ELEMENT SIX (UK) LIMITED | UK (HARWELL OXFORDSHIRE DIDCOT) | participant | 960˙290.00 |
5 | EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH | CH (ZUERICH) | participant | 936˙812.00 |
6 | THE HEBREW UNIVERSITY OF JERUSALEM | IL (JERUSALEM) | participant | 390˙387.00 |
7 | BRUKER BIOSPIN GMBH | DE (RHEINSTETTEN) | participant | 228˙800.00 |
Cardiovascular Diseases (CVDs) are the number 1 cause of death globally: more people die annually from CVDs than from any other cause. Despite emerging diagnostics tools and therapeutics, several areas of significant unmet need remain unaddressed among CVD patients. The ability to personalize cardiovascular medical care and improve outcomes, will require characterization of disease processes at a molecular level. The current state-of-the-art, e.g., Positron emission tomography (PET), does not provide detailed information about the chemical state of the tissue at a molecular level, therefore it remains difficult to accurately diagnose and confidently select appropriate therapy in many circumstances. The MetaboliQs project brings together two areas of European excellence - diamond-based quantum sensing and medical imaging. We will translate a newly developed hyperpolarization method for magnetic resonance imaging (MRI) based on the quantum dynamics of nitrogen-vacancy (NV) centers. This breakthrough quantum technology will enable previously unachievable, highly sensitive quantification of metabolic activity, paving the way for precision diagnostics and better personalized treatment of cardiovascular and other metabolic diseases. For realizing and eventually commercializing the technology, MetaboliQs brings together a world-class multidisciplinary consortium with end to end expertise - leading diamond quantum technology research institutes (Fraunhofer IAF - quantum-grade diamond growth and fabrication, HUJI - quantum sensing) and innovative companies (Element 6 - worldwide leader in synthetic diamonds, NVision - inventor of diamond-based polarization), as well as two expert users of hyperpolarized and cardiovascular MRI (TUM, ETH Zurich - first in continental Europe to conduct clinical trials of hyperpolarized MRI for cardiovascular disease) and the market leader in electron paramagnetic resonance and preclinical MRI (Bruker).
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "METABOLIQS" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "METABOLIQS" are provided by the European Opendata Portal: CORDIS opendata.